HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib - Concepedia

Concepedia

Publication | Open Access

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

DOI Full Paper Access

95

Citations

37

References

2014

Year

Douglas D. Fang, Bin Zhang, Qingyang Gu, Maruja E. Lira, Qiang Xu, Hongye Sun, Maoxiang Qian, Weiqi Sheng, Mark Ozeck, Zhenxiong Wang,

Journal of Thoracic Oncology

Medicinal ChemistryReceptor Tyrosine KinaseSystems BiologyMedicineCell BiologyCell SignalingDrug Discovery

References

	Year	Citations

Page 1